A newly developed website, Drug Launch NetBase Quid, is a tool that drug companies can use to put together a valuable and helpful report that keeps patients on track during their treatment.
It is not just an event but a patient’s entire journey. Its purpose is to provide a managed system in which the flow of information between customers, local and regional sales and distribution centers, and the headquarters, is streamlined. The data sets that have been built up over time have shown that there are clear correlations between different variables during a patient’s journey. Therefore it decided to take advantage and focus specifically on these variables.
The data has been developed over the years through various surveys and studies. The data-driven approach to patient journey improvement is a holistic view of the change in a patient’s health status after treatment. This approach also has the advantage that a person can implement it in different countries with different cultures and languages, which is essential for companies seeking to expand into new markets. With this approach, it is possible to set up a system that fulfills all patients’ needs along their journey while offering comprehensive support and advice at each stage.
How To Nail The Drug Launch
In the first stage of the journey, the focus is on finding a suitable treatment method. Patients turn to general practitioners or specialists for help rather than pharmaceutical companies. It means that there is a need for more direct interaction between the company and patients, not just with doctors. The NetBase Quid system allows pharmaceutical companies to reach out to patients directly and build relationships with them in this initial phase.
The second stage is about putting together an individual treatment plan after doctors have made a diagnosis. In addition to doctors and pharmacists, patients need to be fully engaged in their treatment plans. The NetBase Quid system allows pharmaceutical companies to give patients relevant information about themselves and their situation.
The third stage is about monitoring the patient’s health status during treatment and making any adjustments that are needed. During this stage, patients need as much information as possible about side effects, potential risks, and interactions with other drugs to make adjustments themselves. A central part of the NetBase Quid system is allowing pharmaceutical companies to share information about such side effects with patients in real time.
The final stage of the journey is about maintaining a healthy relationship between the pharma company and patients beyond treatment by providing them with relevant information and support. The NetBase Quid system allows pharmaceutical companies to give out relevant health and lifestyle advice and enable patients to set up a dialogue with other users that have similar conditions or any other health issues. It can be essential, particularly for people with long-term conditions and their families and relatives.
The Drug Launch NetBase Quid approach has been developed based on different years of data from the company’s surveys and other pharmaceutical companies. The benefits of this system are that all actors in the chain of command can benefit from a more efficient system, enabling them to optimize individual treatment plans for patients. As a result, drug companies can improve their sales and market share while achieving higher patient satisfaction.
As stated earlier it can be used as a tool for companies in their quest for new markets, creating a more satisfying relationship between the companies and the patients.